Results 181 to 190 of about 118,257 (252)

Recent Developments in HIV Antivirals: The Prospect of Prophylactic Drugs to Change the Pandemic. [PDF]

Microb Biotechnol
Brüssow H.
europepmc   +1 more source

Genetic diversity and drug resistance mutations of HIV-1 in Ghana: a systematic review of two decades. [PDF]

BMC Infect Dis
Appiah P, Adusei-Poku M, Obeng BM, Osei-Yeboah R, Gbassana G, Agyemang S, Mac-Ankrah L, Jamfaru I, Seshie M, Sraku IK, Ankamah S, Duedu KO, Sagoe KWC.   +12 more
europepmc   +1 more source

HIV protease inhibitors block streptolysin S production. [PDF]

ACS Chem Biol, 2015
Maxson T, Deane CD, Molloy EM, Cox CL, Markley AL, Lee SW, Mitchell DA.   +6 more
europepmc   +1 more source

Incident diabetes after switching to integrase strand transfer inhibitors in people with HIV in the USA and Canada: a cohort study. [PDF]

Lancet HIV
Hwang YJ, Lesko CR, Brown TT, Alexander GC, Althoff KN, Zalla LC, Pytell JD, Falade-Nwulia O, Tseng E, Moore RD, Marconi VC, Koethe JR, Silverberg MJ, Horberg MA, Lang R, Sterling TR, Fojo AT, North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS.   +17 more
europepmc   +1 more source

Brief Report: Is Gestational Exposure to HIV and Protease Inhibitors Associated With Timing of Pubertal Onset? [PDF]

J Acquir Immune Defic Syndr
Serghides L, Lee J, Jacobson DL, Geffner ME, DiMeglio LA, McFarland EJ, Powis KM, Williams PL, Jao J, Pediatric HIV/AIDS Cohort Study.   +9 more
europepmc   +1 more source

Targeting the AKT pathway: Repositioning HIV protease inhibitors as radiosensitizers.

Indian J Med Res, 2016
Goda JS, Pachpor T, Basu T, Chopra S, Gota V.   +4 more
europepmc   +1 more source

Modeling NRTIs and PIs class drug therapy on the dynamics of HIV infection with real patient data analysis and optimized control strategy. [PDF]

Sci Rep
Sardar P, Ranjit B, Biswas S, Boulaaras SM, Allali K, Pal B, Das KP.   +6 more
europepmc   +1 more source

Virtual Screening of FDA-Approved Compounds: Exploring New Alternatives for HIV Treatment. [PDF]

ACS Omega
Martinez DP, Kremer FS.
europepmc   +1 more source

Highly Potent Phosphinic HIV‑1 Protease Inhibitors: Synthesis, In Vitro Evaluation, and Docking Studies. [PDF]

ACS Omega
Hayat K, Qiu D, Wang Y, Imbenzi PS, Khan FI, Matziari M.   +5 more
europepmc   +1 more source

Surface Plasmon Resonance as a Tool in Antiviral Drug Discovery Research. [PDF]

Biosensors (Basel)
Wegrzyn KE, Matsoukas JM.
europepmc   +1 more source